Recent 8-K filings for CMCT
Highest-materiality recent filing
CMCT issues 15.4M common shares to redeem preferred shares, causing dilution
- Issued 15,393,171 common shares to redeem 194,984 preferred shares (105,652 Series A + 89,332 Series A1) at VWAP.
- Redemptions occurred Nov 1–Dec 6, 2024; stock issued instead of cash per holder requests.
-
CMCT Q1 net loss $34.7M; sells lending business for $44.9M, redeems $242.8M preferred stock
Net loss attributable to common stockholders $(34.7M), $(70.52)/diluted share; Core FFO $(5.9M), $(11.89)/diluted share.
-
CMCT issues ~261M common shares in preferred stock redemptions, massive dilution
On March 12, 2026, issued 1,106,594 shares for Series A and 2,322,421 shares for Series A1 Preferred redemptions.
-
CMCT Q4 net loss $17.7M; sells lending business; redeems preferred stock to lift FFO
Net loss attributable to common stockholders $(17.7)M ($(11.20)/diluted share); FFO $(7.1)M ($(4.49)/share); Core FFO $(5.9)M ($(3.74)/share).
-
CMCT completes sale of lending division for $44.9M net of debt, receives $31.2M proceeds
Sold all equity interests of First Western SBLC, LLC to PG FR Holding, LLC (affiliate of Peachtree Group) on January 21, 2026.
-
CMCT reports Q3 net loss $17.7M; sells lending business for $44M, office leasing up 69% YTD
Net loss attributable to common stockholders of $17.7M ($23.52 per share); FFO loss $11.1M, Core FFO loss $10.5M.
-
CMCT agrees to sell lending division to Peachtree Group affiliate for approx. $44 million
Purchase price estimated at $44 million net of debt, yielding ~$31 million net cash proceeds to CMCT.
-
Stockholders approve three reverse stock split ratios up to 1:10
All three reverse split proposals passed: 1:4 (409,794 for, 91,846 against), 1:7 (405,276 for), 1:10 (404,237 for).
-
CMCT shareholders approve adjournment to solicit more votes on reverse stock split proposals
Adjournment vote: 374,139 for, 111,721 against, 6,111 abstentions.
-
CMCT Q2 2025: Net loss $14.3M; same-store office occupancy 70.1%, down 1220 bps YoY
Net loss per diluted share $(18.94); Core FFO per share $(9.53).
-
CMCT reports Q1 net loss of $11.9M, FFO loss $5.4M; repays credit facility with $35.5M mortgage
Net loss attributable to common stockholders of $(11.9)M ($(20.73)/diluted share) vs $(12.3)M in Q1 2024.
-
CMCT subsidiary enters $35.5M mortgage loan with Comerica Bank; repays $15M JPMorgan facility
$35.5M first-lien mortgage loan from Comerica Bank secured by Penn Field office campus in Austin, TX.
-
CMCT shareholders approve 1-for-25 reverse stock split at special meeting
Proposal approved with 8,344,683 for, 665,696 against, 61,621 abstain; no broker non-votes.
-
CMCT Q4 2024 net loss $1.78/shr; Core FFO -$0.75; debt reduced to $15M
Net loss $16.6M ($1.78/shr); FFO -$8.7M (-$0.93/shr); Core FFO -$7.0M (-$0.75/shr).
-
CMCT extends $15M credit facility maturity to March 31, 2025 via fourth modification
Fourth Modification Agreement with JPMorgan extends maturity from Jan 31, 2025 to March 31, 2025.
-
CMCT extends lease with Kaiser Foundation Health Plan on 236,692 sq ft through 2027
Lease extension effective Dec 30, 2024, covers all 236,692 rentable sq ft at 1 Kaiser Plaza, Oakland.
-
CMCT effects 1-for-10 reverse stock split; issues ~1.5M common shares for preferred redemptions
Reverse stock split effective Jan 6, 2025, combining every 10 common shares into 1 share; par value temporarily adjusted to $0.01, then reverted to $0.001.
-
CMCT obtains $105M mortgage loan from Wells Fargo, BofA, JPMorgan at 7.413% fixed rate
$105M first lien mortgage loan secured by three office buildings in Beverly Hills and Los Angeles.
-
CMCT issues ~14.2M common shares for redemption of 139K preferred shares in Dec 2024
On Dec 10, 18, and 19, 2024, CMCT issued 14,241,564 common shares in lieu of cash for 139,263 Series A/A1 preferred redemptions.
-
CMCT issues 15.4M common shares to redeem preferred shares, causing dilution
Issued 15,393,171 common shares to redeem 194,984 preferred shares (105,652 Series A + 89,332 Series A1) at VWAP.
-
Loan of up to $92.2M includes $84.3M closing advance to pay down $71.9M existing debt and fund hotel renovations.
-
CMCT largest tenant at 1 Kaiser Plaza signs LOI to extend 152,966 sq ft through Feb 2027
Non-binding LOI to extend 152,966 rentable square feet of office space at 1 Kaiser Plaza, Oakland, CA.
-
CMCT reports Q3 net loss $34.8M; receives Nasdaq delisting notice for bid price below $1.00
Net loss attributable to common stockholders of $34.8M ($1.22 per diluted share) vs $22.9M loss in Q3 2023.
-
Lenders waived an event of default for non-compliance with a financial covenant for the test period ending Sep 30, 2024.
-
CMCT issues ~60.5M common shares to redeem Series A and A1 Preferred Stock
Issued 25,950,415 common shares for Series A Preferred and 29,958,074 for Series A1 Preferred on Sep 23, 2024.
-
CMCT Q2 2024 net loss $9.7M; Core FFO $(0.09)/share, improved YoY
Net loss attributable to common stockholders $9.7M ($0.43/diluted share) vs $23.8M loss in Q2 2023.
-
CMCT Q1 net loss $12.3M; core FFO falls to $(4.4)M on higher interest costs
Net loss $12.3M ($0.54/diluted) vs $12.7M loss ($0.56) in Q1 2023.
-
CMCT Q4 2023 net loss $16.3M, FFO loss $9.9M; office same-store 84% leased
Net loss $16.3M ($0.72/sh) vs $8.9M loss in Q4 2022; Core FFO loss $8.4M ($0.37/sh) vs $4.4M positive.
-
CMCT Q3 net loss widens to $22.9M ($1.01/sh); FFO negative $7.5M
Net loss attributable to common stockholders of $22.9M, or $1.01 per diluted share, vs. $11.7M ($0.50) in Q3 2022.
-
CMCT reports $23.8M net loss in Q2 2023; Core FFO negative $0.17 per share
Net loss attributable to common stockholders of $23.8M ($1.05/diluted share) vs loss of $2.3M a year ago.
Earnings & guidance
Materiality & sentiment trend
Max materiality 0.95 · Median 0.65 · Most common event other_material